North Star Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
AIM
AV
North Star Investment Management's AZN Position: Q2 2026 in Review
North Star Investment Management reduced its AstraZeneca (AZN) stake by 3.5% in Q2 2026, selling an estimated $4.51K and leaving 656 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #574.
North Star Investment Management first reported a position in AZN in Q1 2014 and has held it in 25 quarters since. The position peaked at $134K in Q1 2026. 578 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- North Star Investment Management held 656 shares of AstraZeneca worth $124K as of Q2 2026.
- North Star Investment Management sold 24 AstraZeneca shares in Q2 2026, an estimated $4.51K.
- AstraZeneca made up 0.01% of North Star Investment Management's portfolio in Q2 2026, its #574 holding.
- North Star Investment Management first reported a position in AstraZeneca in Q1 2014 and has held it in 25 quarters since.
- North Star Investment Management's AstraZeneca position peaked at $134K in Q1 2026.
- 578 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.